Status
Conditions
Treatments
About
This study aims to compare Neutrophil to Lymphocyte and Platelet Ratio, Procalcitonin, and Total Leucocyte Count as indicators of prognostic outcome in septic patients in the intensive care unit.
Full description
Sepsis affects more than 30 million people annually worldwide and is one of the significant causes of death in critical patients worldwide. Any infected person can potentially develop sepsis, and the incidence of sepsis is as high as 1-2% of all hospitalized patients.
Many potential sepsis biomarkers have been proposed, procalcitonin (PCT) and C-reactive protein (CRP) being the most frequently studied.
The ratio of neutrophils to lymphocytes and platelets (N/LP) is a low-cost measure that can be obtained through routine blood tests and is often used to reflect the body's inflammatory state.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
290 participants in 1 patient group
Loading...
Central trial contact
Michael G Farag, Master
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal